Triple
T1103716
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Leqembi |
E25439
|
entity |
| Predicate | hasKeyClinicalTrial |
P23163
|
FINISHED |
| Object |
Study 301
Study 301 is a pivotal clinical trial evaluating the efficacy and safety of the Alzheimer’s disease drug Leqembi (lecanemab) in patients with early-stage disease.
|
E125384
|
NE FINISHED |
Provenance (5 batches)
| Stage | Batch ID | Job type | Status |
|---|---|---|---|
| creating | batch_69a49428d4448190b3b36991ceae87ce |
elicitation | completed |
| NER | batch_69a4bb75eec08190b1d6545e96816d34 |
ner | completed |
| NED1 | batch_69ac4c4a402081908ee138257425a336 |
ned_source_triple | completed |
| NED2 | batch_69ac4d4cbed88190ac743160198493b2 |
ned_description | completed |
| NEDg | batch_69ac4ccf989c8190aed2ff01ad6fbcab |
nedg | completed |
Created at: March 1, 2026, 7:43 p.m.